Burns v. Copley
Opinion
F I L E D
United States Court of Appeals Tenth Circuit
UNITED STATES COURT OF APPEALS DEC 11 1997
FOR THE TENTH CIRCUIT
PATRICK FISHER
Clerk
In re: COPLEY PHARMACEUTICAL, INC., “Albuterol” Products Liability Litigation.
No. 96-8054
______________________________ (D.C. No. 94-MDL-1013 &
JAMES BURNS and VICKIE BURNS, 96-1601-MDL)
personally and as parents and (D. Wyo.)
guardians of Jimmy Burns,
Plaintiffs-Appellants,
v.
COPLEY PHARMACEUTICAL, INC.,
Defendant-Appellee,
and NATIONAL PHARMACIES, INC., Defendant.
ORDER AND JUDGMENT *
*
This order and judgment is not binding precedent, except under the doctrines of law of the case, res judicata, and collateral estoppel. The court generally disfavors the citation of orders and judgments; nevertheless, an order and judgment may be cited under the terms and conditions of 10th Cir. R. 36.3.
Before PORFILIO and LUCERO, Circuit Judges, and MARTEN, ** District Judge.
After examining the briefs and appellate record, this panel has determined unanimously to grant the parties’ request for a decision on the briefs without oral argument. See Fed. R. App. P. 34(f) and 10th Cir. R. 34.1.9. The case is therefore ordered submitted without oral argument.
Plaintiffs-appellants James and Vickie Burns (the Burnses) seek review of an order of the district court denying their untimely motion to opt out of a multidistrict class action against defendant-appellee Copley Pharmaceutical, Inc., the manufacturer of a prescription drug, albuterol sulfate inhalation solution (albuterol). The Burnses had filed an individual lawsuit, alleging that Copley and National Pharmacies, Inc., a seller of albuterol, are liable for the death of their child. We reverse and remand for additional findings.
BACKGROUND
The Burnses filed their action on November 1, 1995, in South Carolina state court. At the time, Copley was the defendant in numerous other lawsuits, initiated after it had announced a voluntary recall of batches of contaminated
**
The Honorable J. Thomas Marten, District Judge, United States District Court for the District of Kansas, sitting by designation.
albuterol. Previously, the judicial panel for multi-district litigation had consolidated the federal cases brought against Copley in the United States District Court for the District of Wyoming. On October 28, 1994, that court had certified the multi-district action as a Fed. R. Civ. P. 23(b)(3) class action of “[a]ll persons throughout the United States and its territories who suffered damages as a result of the inhalation of Albuterol manufactured, supplied, distributed or placed in commerce by Copley Pharmaceutical, Inc.” In re Copley Pharm., Inc., (“Albuterol” Prod. Liability Litig.), 158 F.R.D. 485, 493 (D. Wyo. 1994). 1 Class counsel was ordered to give notice of the action by direct mail to potential class members known to Copley 2 and class counsel, and by publication in USA Today and speciality magazines. The district court set the opt-out
1 An account of the factual allegations, claims, and defenses in the class action can be found in the district court’s order granting partial class certification. See In re Copley Pharm., 158 F.R.D. at 487. See also In re Copley Pharm., Inc. (“Albuterol” Prod. Liability Litig., 161 F.R.D. 456 (D. Wyo. 1995) (order denying defendant’s motion to decertify the class and the court’s trial plan). 2 Copley was ordered to provide the names, addresses and phone numbers of all persons who may be considered members of the class, including persons identified from customer complaints, responses to recall notices, the lists of a claims service, lists provided by pharmacists or distributors, and lists of potential class members who had settled with Copley. Without making specific findings tied to the evidence, the district court declined Copley’s request to require class counsel to send notice to pharmacists, which was “how people were notified of the problem” during the recall, Appellee’s Suppl. App. at 120-21. See also In re Copley Pharm,, 158 F.R.D. at 493 (in certifying class, the district court noted that “notice should not be terribly complicated [ ] [b]ecause Albuterol was distributed through prescriptions and Copley has already contacted distributors through its recall”).
deadline of March 15, 1995. The parties reached a settlement on August 22, 1995, which the court preliminarily approved on August 28, 1995.
The following month, the Burnses learned of the class action from a physician who was treating their child. After contacting attorneys, they filed a motion to opt out of the class on October 20, 1995, and commenced their action in state court. The case was removed to federal court and included in the class action. On November 15, 1995, the district court entered an order finally approving the class action settlement. It did not enter the final order of dismissal required by the agreement 3 and retained jurisdiction to administer the agreement. On May 3, 1996, the district court denied the Burnses’ motion to opt out, and allowed them thirty days to file a proof of claim. Rather than proceeding with their claim in the class action, the Burnses filed this appeal.
3 The settlement agreement is expressly conditioned upon the entry of an order dismissing with prejudice the class action and the other cases transferred by the judicial panel on multidistrict litigation.
DISCUSSION
A. Jurisdiction We first examine whether we have jurisdiction over this appeal, in light of the lack of a dismissal order and the district court’s continuing administration of the settlement. As we have previously explained, under 28 U.S.C. § 1291,
we have jurisdiction only over “final” decisions of the district court;
that is, those decisions that leave nothing for the court to do but execute the judgment. Notably, a decision “final” within the meaning of § 1291 does not necessarily mean the last order possible to be made in a case. Thus, a district court’s decision is appealable if it falls within “that small class which finally determine claims of right separable from, and collateral to, rights asserted in the action, too important to be denied review and too independent of the cause itself to require that appellate consideration be deferred until the whole case is adjudicated.” Cohen v. Beneficial Industrial Loan Corp., 337 U.S. 541, 546 (1949).
To come within Cohen’s collateral order doctrine, an order must [1] conclusively determine the disputed question, [2] resolve an important issue completely separate from the merits of the action, and [3] be effectively unreviewable on appeal from a final judgment.
Myers v. Oklahoma County Bd. of County Comm’rs, 80 F.3d 421, 425 (10th Cir.),
cert. denied, 117 S. Ct. 383 (1996) (further citations and quotations omitted).
The circumstances of this case meet all three of the requirements of the collateral order doctrine. The denial of the motion to opt out (1) conclusively determines the status of the Burnses’ separate lawsuit; (2) resolves the Burnses’ claims concerning the adequacy of notice, which are separate from the merits of the class action’s settlement agreement; and (3) will be unreviewable on an appeal
from final judgment, in that the district court’s order effectively binds the Burnses to the terms of the settlement agreement. We therefore conclude that the challenged order amounts to a final decision and we exercise our jurisdiction pursuant to § 1291.
Free access — add to your briefcase to read the full text and ask questions with AI
Burns v. Copley (Burns v. Copley) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.